Jeffrey Bluestone
Director/Board Member chez GILEAD SCIENCES, INC.
Fortune : 418 111 $ au 31/03/2024
Profil
Jeffrey A.
Bluestone is the founder of Celsius Therapeutics, Inc. (founded in 2018), Xconomy, Inc. (founded in 2007), Immune Tolerance Network (founded in 1999), and Sonoma Biotherapeutics, Inc. (founded in 2019).
He is currently the Vice Chairman at The Parker Institute For Cancer Immunotherapy since 2015, an Independent Director at Gilead Sciences, Inc. since 2020, a Professor at The University of California, San Francisco, and a Member of both the American Academy of Arts & Sciences and the National Academy of Medicine (United States).
He previously served as an Independent Director at Provention Bio, Inc. from 2019 to 2022, a Director at Rheos Medicines, Inc., and the Director & Professor at The Ben May Department For Cancer Research.
Dr. Bluestone received a graduate degree from Rutgers State University of New Jersey and a doctorate degree from Weill Cornell Graduate School of Medical Sciences.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
GILEAD SCIENCES, INC.
0,00% | 29/02/2024 | 5 708 ( 0,00% ) | 418 111 $ | 31/03/2024 |
Postes actifs de Jeffrey Bluestone
Sociétés | Poste | Début |
---|---|---|
GILEAD SCIENCES, INC. | Director/Board Member | 07/12/2020 |
Celsius Therapeutics, Inc.
Celsius Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Celsius Therapeutics, Inc. translates single-cell genomic insights into precision therapeutics for autoimmune diseases and cancer. The company was founded by Jeffrey A. Bluestone, Vijay K. Kuchroo, Christoph S. Lengauer, Aviv Regev and Ramnik Xavier in 2018 and is headquartered in Boston, MA. | Founder | 01/01/2018 |
The Parker Institute For Cancer Immunotherapy
The Parker Institute For Cancer Immunotherapy Miscellaneous Commercial ServicesCommercial Services The Parker Institute for Cancer Immunotherapy is a research organization that aims to accelerate the development of breakthrough immune therapies to turn all cancers into curable diseases. The Parker Institute for Cancer Immunotherapy is based in San Francisco, CA. The private company conducts clinical trials to tackle the toughest cancers and answer the hardest questions in immunotherapy. The institute coordinates cancer research efforts between the best scientists, clinicians, and partners in the industry. The company has legal experts who help their researchers navigate the intellectual property process and turn their cancer immunotherapy discoveries into treatments. It was founded by Sean N. Parker, Adam Kolom, Michael Polansky. | Director/Board Member | 09/04/2020 |
Sonoma Biotherapeutics, Inc.
Sonoma Biotherapeutics, Inc. BiotechnologyHealth Technology Sonoma Biotherapeutics, Inc. provides research, development, and manufacturing capabilities in cell therapy and genetic engineering. The company was founded by Jeffrey A. Bluestone, Fred Ramsdell, Alexander Rudensky, and Qizhi Tang in 2019 and is headquartered in South San Francisco, CA. | Founder | 01/01/2019 |
Xconomy, Inc.
Xconomy, Inc. Internet Software/ServicesTechnology Services Xconomy, Inc. provides business, life sciences, and technology news for business and technology leaders. It offers information about the local personalities, companies, and technological trends that exemplify today's high-technology economy. The firm provides its content through a network of localized blogs, events, conferences, and other initiatives designed to connect people and ideas. It has offices in Boston, Boulder, Denver, Detroit, New York, San Diego, San Francisco, Seattle and Texas. The company was founded by Rebecca Zacks and Robert Buderi on June 27, 2007 and is headquartered in Boston, MA. | Chief Executive Officer | - |
The University of California, San Francisco | Corporate Officer/Principal | - |
National Academy of Medicine (United States)
National Academy of Medicine (United States) Miscellaneous Commercial ServicesCommercial Services The National Academy of Medicine (United States) is based in Washington and is focused on improving the health and well-being of individuals through various initiatives. These initiatives include the clinician well-being collaborative, which aims to accelerate the implementation of a national plan for health workforce well-being, and the development of a code of conduct for the use of artificial intelligence in health care. The organization also provides resources to support meaningful community engagement in health and health care programs and policies. Recently, the National Academy of Medicine announced the appointment of Mandy Cohen, a member of the organization, as the director of the Centers for Disease Control and Prevention. Additionally, the organization has released a publication celebrating 50 years of progress in biomedical science, health, and health care. | Corporate Officer/Principal | - |
American Academy of Arts & Sciences
American Academy of Arts & Sciences Miscellaneous Commercial ServicesCommercial Services The American Academy of Arts & Sciences is an organization that honors excellence and brings together leaders. The non-profit company is based in Cambridge, MA. | Corporate Officer/Principal | - |
Anciens postes connus de Jeffrey Bluestone
Sociétés | Poste | Fin |
---|---|---|
PROVENTION BIO, INC. | Director/Board Member | 01/06/2022 |
░░░░░ ░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
░░░ ░░░ ░░░ ░░░░░░░░░░ ░░░ ░░░░░░ ░░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
░░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░ | - |
Formation de Jeffrey Bluestone
Rutgers State University of New Jersey | Graduate Degree |
Weill Cornell Graduate School of Medical Sciences | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
GILEAD SCIENCES, INC. | Health Technology |
Entreprise privées | 9 |
---|---|
Xconomy, Inc.
Xconomy, Inc. Internet Software/ServicesTechnology Services Xconomy, Inc. provides business, life sciences, and technology news for business and technology leaders. It offers information about the local personalities, companies, and technological trends that exemplify today's high-technology economy. The firm provides its content through a network of localized blogs, events, conferences, and other initiatives designed to connect people and ideas. It has offices in Boston, Boulder, Denver, Detroit, New York, San Diego, San Francisco, Seattle and Texas. The company was founded by Rebecca Zacks and Robert Buderi on June 27, 2007 and is headquartered in Boston, MA. | Technology Services |
American Academy of Arts & Sciences
American Academy of Arts & Sciences Miscellaneous Commercial ServicesCommercial Services The American Academy of Arts & Sciences is an organization that honors excellence and brings together leaders. The non-profit company is based in Cambridge, MA. | Commercial Services |
National Academy of Medicine (United States)
National Academy of Medicine (United States) Miscellaneous Commercial ServicesCommercial Services The National Academy of Medicine (United States) is based in Washington and is focused on improving the health and well-being of individuals through various initiatives. These initiatives include the clinician well-being collaborative, which aims to accelerate the implementation of a national plan for health workforce well-being, and the development of a code of conduct for the use of artificial intelligence in health care. The organization also provides resources to support meaningful community engagement in health and health care programs and policies. Recently, the National Academy of Medicine announced the appointment of Mandy Cohen, a member of the organization, as the director of the Centers for Disease Control and Prevention. Additionally, the organization has released a publication celebrating 50 years of progress in biomedical science, health, and health care. | Commercial Services |
Immune Tolerance Network
Immune Tolerance Network Miscellaneous Commercial ServicesCommercial Services Immune Tolerance Network provides clinical research services. It offers immune tolerance therapies for autoimmune disease, allergies and asthma, organ transplantation, and type 1 diabetes. The company was founded by Jeffrey A. Bluestone in 1999 and is headquartered in Seattle, WA. | Commercial Services |
Provention Bio, Inc.
Provention Bio, Inc. Pharmaceuticals: MajorHealth Technology Provention Bio, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of novel therapeutics and solutions. Its products include PRV-031 for the interception of type 1 diabetes (T1D), PRV-015 for the treatment of gluten-free diet non-responding celiac disease, PRV-6527 for Crohn’s disease, PRV-3279 for the treatment of lupus, and PRV-101 for the prevention of acute coxsackie virus B (CVB), and the prevention of type 1 diabetes (T1D) onset. The company was founded by Francisco Leon and Ashleigh Palmer on October 4, 2016 and is headquartered in Red Bank, NJ. | Health Technology |
The Parker Institute For Cancer Immunotherapy
The Parker Institute For Cancer Immunotherapy Miscellaneous Commercial ServicesCommercial Services The Parker Institute for Cancer Immunotherapy is a research organization that aims to accelerate the development of breakthrough immune therapies to turn all cancers into curable diseases. The Parker Institute for Cancer Immunotherapy is based in San Francisco, CA. The private company conducts clinical trials to tackle the toughest cancers and answer the hardest questions in immunotherapy. The institute coordinates cancer research efforts between the best scientists, clinicians, and partners in the industry. The company has legal experts who help their researchers navigate the intellectual property process and turn their cancer immunotherapy discoveries into treatments. It was founded by Sean N. Parker, Adam Kolom, Michael Polansky. | Commercial Services |
Rheos Medicines, Inc.
Rheos Medicines, Inc. BiotechnologyHealth Technology Rheos Medicines, Inc. operates as a biopharmaceutical firm. It develops novel medicines that modulate metabolic pathways in immune cells to treat disease. The company was founded by Erika Pearce, Edward Pearce, Laurence Turka, Richard Flavell, Ken Smith, and E. William St. Clair and is headquartered in Cambridge, MA. | Health Technology |
Celsius Therapeutics, Inc.
Celsius Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Celsius Therapeutics, Inc. translates single-cell genomic insights into precision therapeutics for autoimmune diseases and cancer. The company was founded by Jeffrey A. Bluestone, Vijay K. Kuchroo, Christoph S. Lengauer, Aviv Regev and Ramnik Xavier in 2018 and is headquartered in Boston, MA. | Health Technology |
Sonoma Biotherapeutics, Inc.
Sonoma Biotherapeutics, Inc. BiotechnologyHealth Technology Sonoma Biotherapeutics, Inc. provides research, development, and manufacturing capabilities in cell therapy and genetic engineering. The company was founded by Jeffrey A. Bluestone, Fred Ramsdell, Alexander Rudensky, and Qizhi Tang in 2019 and is headquartered in South San Francisco, CA. | Health Technology |